bioMérieux Share Price

Equities

BIM

FR0013280286

Medical Equipment, Supplies & Distribution

Market Closed - Euronext Paris 16:35:22 24/06/2024 BST Pre-market 07:45:28
90.45 EUR +1.80% Intraday chart for bioMérieux 89.48 -1.08%

Financials

Sales 2024 * 3.9B 4.19B 330B Sales 2025 * 4.19B 4.5B 355B Capitalization 10.69B 11.47B 904B
Net income 2024 * 465M 499M 39.35B Net income 2025 * 527M 566M 44.59B EV / Sales 2024 * 2.7 x
Net cash position 2024 * 153M 164M 12.96B Net cash position 2025 * 400M 429M 33.85B EV / Sales 2025 * 2.45 x
P/E ratio 2024 *
23.5 x
P/E ratio 2025 *
20.7 x
Employees 13,696
Yield 2024 *
0.98%
Yield 2025 *
1.15%
Free-Float 36.23%
More Fundamentals * Assessed data
Dynamic Chart
1 day+1.80%
1 week-0.39%
Current month-6.90%
1 month-5.44%
3 months-10.09%
6 months-10.45%
Current year-10.09%
More quotes
1 week
88.35
Extreme 88.35
91.80
1 month
88.35
Extreme 88.35
97.55
Current year
88.35
Extreme 88.35
108.90
1 year
84.54
Extreme 84.54
108.90
3 years
77.48
Extreme 77.48
133.20
5 years
67.45
Extreme 67.45
144.80
10 years
25.44
Extreme 25.44
144.80
More quotes
Managers TitleAgeSince
Chief Executive Officer 52 31/10/16
Chairman 50 15/04/04
Director of Finance/CFO 47 28/02/18
Members of the board TitleAgeSince
Director/Board Member 74 14/09/06
Director/Board Member 63 31/12/04
Chairman 50 15/04/04
More insiders
Date Price Change Volume
24/06/24 90.45 +1.80% 89,636
21/06/24 88.85 -0.84% 349,036
20/06/24 89.6 -0.33% 71,237
19/06/24 89.9 -1.69% 62,564
18/06/24 91.45 +0.72% 87,114

Real-time Euronext Paris, June 24, 2024 at 04:35 pm

More quotes
bioMérieux designs, develops, produces, and sells systems used in clinical practice to diagnose infectious diseases (including HIV, tuberculosis, and respiratory infections), cancers, and cardiovascular pathologies based on a biological sample (blood, saliva, urine, etc.). Net sales break down by sector of application as follows: - medical applications (84.4%): in industry, microbiological testing of samples from finished products, materials during the manufacturing process, or the environment, primarily in the food-processing, pharmaceutical, and cosmetics sectors; - industrial applications (15.6%). The group's diagnostic systems consist of three elements with related services: reagents, instruments (or platforms or analyzers), software, and services. Net sales are distributed geographically as follows: Europe/Middle East/Africa (32.4%), North America (44.1), Asia/Pacific (17.3%) and Latin America (6.2%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
90.45 EUR
Average target price
113.5 EUR
Spread / Average Target
+25.46%
Consensus